Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Documento de consenso SEIP-AEPAP-SEPEAP sobre la etiologia, el diagnostico y el tratamiento de las infecciones cutaneas bacterianas de manejo ambulatorio Conejo-Fernandez AJ; Martinez-Chamorro MJ; Couceiro JA; Moraga-Llop FA; Baquero-Artigao F; Alvez F; Vera Casano A; Pineiro-Perez R; Alfayate S; Cilleruelo MJ; Calvo CAn Pediatr (Barc) 2016[Feb]; 84 (2): 121.e1-121.e10Skin infections are a common cause for dermatological consultations in the paediatric setting. A review is presented of the clinical manifestations, diagnosis and treatment of the main bacterial skin infections, as well as the diagnosis and treatment of super-infected puncture and bite wounds. The most prevalent bacteria in skin infections are Staphylococcus aureus and Streptococcus pyogenes. Treatment is usually empirical, since microbiological studies are only recommended under certain circumstances or lack of improvement with common therapies. Superficial skin infections can be treated with local antiseptics or antibiotics (mupirocin or fusidic acid). Systemic treatment is usually reserved for patients with extensive or severe disease or with other risk factors. Systemic treatment depends on the suspected infecting bacteria, with penicillin, amoxicillin, amoxicillin-clavulanic acid and first or second generation cephalosporin being the most frequently used drugs. Due to the low incidence of community-acquired methicillin-resistant infection by S. aureus in Spain, the use of clindamycin or co-trimoxazole is only recommended after severe disease, relapses or a clear epidemiological background.|Anti-Bacterial Agents/therapeutic use[MESH]|Clindamycin/therapeutic use[MESH]|Community-Acquired Infections/drug therapy[MESH]|Consensus[MESH]|Humans[MESH]|Outpatients[MESH]|Pediatrics[MESH]|Spain[MESH]|Staphylococcal Skin Infections/*diagnosis/*therapy[MESH]|Staphylococcus aureus[MESH]|Streptococcal Infections/*diagnosis/*therapy[MESH]|Streptococcus pyogenes[MESH] |